At the same time, it was found that IL-17A could induce mitochondrial dysfunction and pyroptosis through ROS/NLRP3/caspase-4/GSDMD pathway and promote intracellular ROS accumulation in CRC patients. This evidence concerns the gene IL17A and colorectal carcinoma.